TLDR
- IonQ filed a prospectus with the SEC to allow the University of Cambridge to resell 2,562,642 of its common stock.
- The filing follows a Registration Rights Agreement signed Tuesday between IonQ and Cambridge.
- Separately, IonQ announced a deal with Cambridge to establish the IonQ Quantum Innovation Centre on campus.
- The partnership includes deploying IonQ’s 256-qubit system at Cambridge and a shared IP and licensing agreement.
- IONQ stock is down 21.7% year-to-date but up 87.8% over the past 12 months, trading at $35.12.
IonQ filed a prospectus supplement with the SEC on Wednesday, registering 2,562,642 shares of its common stock for resale by the University of Cambridge.
The shares were originally issued in a private transaction under Section 4(a)(2) of the Securities Act of 1933 and/or Rule 506 of Regulation D — standard exemptions used in private placements.
The filing was made under a Registration Rights Agreement dated Tuesday between IonQ and the University of Cambridge. That agreement gives Cambridge the right to sell those shares on the open market.
Legal opinions for the filing were provided by Paul, Weiss, Rifkind, Wharton & Garrison LLP.
IONQ stock was fractionally higher in premarket trading Wednesday. The stock currently sits at $35.12, putting IonQ’s market cap at roughly $12.88 billion.
The stock has had a rough start to 2026, falling 21.7% year-to-date. Over the past 12 months, though, it’s up 87.8%.
The share resale filing wasn’t the only news out of IonQ on Wednesday.
IonQ Quantum Innovation Centre at Cambridge
The company also announced a separate agreement with the University of Cambridge to establish the IonQ Quantum Innovation Centre on campus.
Under the deal, Cambridge will deploy IonQ’s 6th-generation, chip-based, 256-qubit system on its campus. The university will also get access to IonQ’s quantum cloud platform.
The agreement covers joint research and development across quantum computing, networking, sensing, and security. It also includes a shared licensing arrangement on any resulting intellectual property.
“This historic agreement with Cambridge deepens IonQ’s commitment to the United Kingdom,” said CEO Niccolo de Masi. “By establishing the IonQ Quantum Innovation Center, we are strengthening the bridge between academic discovery and commercial quantum advantage.”
Analyst Views on IONQ
This is IonQ’s second prospectus supplement filed recently. The company previously filed to cover the resale of over 5.1 million shares of common stock.
On the analyst side, Benchmark recently cut its price target for IonQ to $65, citing concerns about revenue mix — but kept its Buy rating. The firm noted IonQ’s core computing business grew over 80% year-over-year.
Morgan Stanley raised its price target to $37, maintaining an Equalweight rating. The firm pointed to strong organic and inorganic growth.
IonQ also recently partnered with the Applied Research Laboratory for Intelligence and Security on a quantum computing security program. That program is sponsored by the Secretary of the Air Force’s Concepts, Development, and Management Office.
IONQ stock trades on the New York Stock Exchange under the ticker IONQ
Considering a new stock? You may want to see what’s on our watchlist first.
Our team at Knockout Stocks follows top-performing analysts and market-moving trends to spot potential winners early. We’ve identified five stocks gaining quiet attention that could be worth watching now. Create your free account to unlock the full report and get ongoing stock insights.Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
